Koninklijke Philips NV
PHG29.460USD
+0.580+2.01%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
28.02BCap. mercado
145.65P/E TTM
Más Datos de Koninklijke Philips NV Compañía
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Información de Koninklijke Philips NV
Símbolo de cotizaciónPHG
Nombre de la empresaKoninklijke Philips NV
Fecha de salida a bolsaSep 18, 2009
Director ejecutivoJakobs (Roy)
Número de empleados67823
Tipo de seguridadDepository Receipt
Fin del año fiscalSep 18
DirecciónHigh Tech Campus 5
CiudadEINDHOVEN
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísNetherlands
Código postal5656 AE
Teléfono31205977777
Sitio Webhttps://www.philips.com/
Símbolo de cotizaciónPHG
Fecha de salida a bolsaSep 18, 2009
Director ejecutivoJakobs (Roy)
Ejecutivos de Koninklijke Philips NV
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Board of Management, Chief Executive Officer
Chairman of the Board of Management, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Mr. Leandro Mazzoni
Mr. Leandro Mazzoni
Head of Investor Relations
Head of Investor Relations
--
--
Ms. Deeptha Khanna
Ms. Deeptha Khanna
Executive Vice President, Chief Business Leader Personal Health
Executive Vice President, Chief Business Leader Personal Health
--
--
Mr. Peter Loescher
Mr. Peter Loescher
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Feike Sijbesma
Mr. Feike Sijbesma
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
Executive Vice President, Member of the Board of Management, Chief ESG & Legal Officer
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Board of Management, Chief Executive Officer
Chairman of the Board of Management, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
North America
2.14B
42.61%
Growth geographies
1.42B
28.29%
Western Europe
1.09B
21.69%
Other Mature geographies
374.02M
7.44%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.75%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.21%
Otro
97.47%
Accionistas
Accionistas
Proporción
Mondrian Investment Partners Ltd.
0.83%
Fiduciary Management, Inc.
0.75%
Dimensional Fund Advisors, L.P.
0.47%
Fidelity Management & Research Company LLC
0.27%
Causeway Capital Management LLC
0.21%
Otro
97.47%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
4.05%
Investment Advisor/Hedge Fund
0.82%
Research Firm
0.23%
Hedge Fund
0.19%
Family Office
0.05%
Family Office
0.04%
Family Office
0.04%
Bank and Trust
0.02%
Otro
94.55%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
581
50.49M
5.31%
-12.67M
2025Q3
564
51.04M
5.37%
-17.40M
2025Q2
560
58.95M
6.20%
-8.73M
2025Q1
579
60.52M
6.54%
-8.45M
2024Q4
583
60.06M
6.49%
-29.02M
2024Q3
590
63.64M
6.83%
-28.01M
2024Q2
594
65.28M
6.99%
-29.22M
2024Q1
610
73.19M
7.82%
-21.31M
2023Q4
642
73.00M
7.79%
-18.85M
2023Q3
666
68.56M
7.24%
-21.16M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Mondrian Investment Partners Ltd.
7.91M
0.83%
+794.94K
+11.18%
Sep 30, 2025
Fiduciary Management, Inc.
7.18M
0.75%
-284.22K
-3.81%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
4.44M
0.47%
-56.61K
-1.26%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.60M
0.27%
+171.68K
+7.08%
Sep 30, 2025
Causeway Capital Management LLC
1.96M
0.21%
+107.12K
+5.79%
Sep 30, 2025
Parametric Portfolio Associates LLC
1.83M
0.19%
+109.23K
+6.35%
Sep 30, 2025
Northern Trust Global Investments
1.64M
0.17%
+121.24K
+7.99%
Sep 30, 2025
Brandes Investment Partners, L.P.
1.62M
0.17%
+87.72K
+5.73%
Sep 30, 2025
Envestnet Asset Management, Inc.
1.30M
0.14%
-51.03K
-3.78%
Sep 30, 2025
Aperio Group, LLC
1.29M
0.14%
+13.78K
+1.08%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Langar Global HealthTech ETF
5.12%
Brandes International ETF
1.99%
Brandes US Small-Mid Cap Value ETF
1.17%
ActivePassive International Equity ETF
0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
0.14%
Avantis Responsible International Equity ETF
0.12%
State Street SPDR S&P Kensho New Econ Comp ETF
0.1%
DFA Dimensional International Core Equity 2 ETF
0.09%
Avantis International Equity ETF
0.08%
Dimensional International Core Equity Market ETF
0.07%
Ver más
Langar Global HealthTech ETF
Proporción5.12%
Brandes International ETF
Proporción1.99%
Brandes US Small-Mid Cap Value ETF
Proporción1.17%
ActivePassive International Equity ETF
Proporción0.24%
DFA Dimensional Intl Sustainability Core 1 ETF
Proporción0.14%
Avantis Responsible International Equity ETF
Proporción0.12%
State Street SPDR S&P Kensho New Econ Comp ETF
Proporción0.1%
DFA Dimensional International Core Equity 2 ETF
Proporción0.09%
Avantis International Equity ETF
Proporción0.08%
Dimensional International Core Equity Market ETF
Proporción0.07%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
